Senior insider sale
See Remarks at ASCENDIS PHARMA A/S — senior position signals high conviction
$7.05M
29.74K shares
What this filing means
JENSEN FLEMMING STEEN plans to sell 29.74K shares of ASCENDIS PHARMA A/S valued at approximately $7.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001973379-26-000168
Officer· See Remarks
Since Mar 2026
29.74K
Shares to sell
$7.05M
Approx. market value
19.46K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
SHARE PLAN ACCOUNT
COMPENSATION
5/11/2026
19.46KTotal acquired19.46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/11/2026 | SHARE PLAN ACCOUNT COMPENSATION | 19.46K | — |
| Total | 19.46K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10.28K
Market value
$2.41M
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
19.46K
Market value
$4.64M
5/11/2026
Total
Units
29.74K
Value
$7.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 10.28K | $2.41M | — | Completed |
| Planned — Approximate Date | ||||
5/11/2026 | 19.46K | $4.64M | NASDAQ | Planned |
| Total | 29.74K | $7.05M | ||